CD80(也称为B7-1)是一种重要的免疫共刺激分子,属于B7基因家族(B7 family),该家族成员(如CD86/B7-2、ICOS-L等)的共同特点是表达于抗原呈递细胞(APC)表面,通过与T细胞表面的受体结合调控免疫应答。CD80主要表达于树突状细胞、B细胞和巨噬细胞等APC上,其配体是T细胞表面的CD28(激活信号)和CTLA-4(抑制信号)。CD80与CD28结合后提供第二信号(共刺激信号),促进T细胞活化、增殖及细胞因子(如IL-2)分泌,这对适应性免疫的启动至关重要;而与CTLA-4结合则会抑制T细胞过度激活,维持免疫稳态。CD80的突变或表达异常可能导致免疫失调,例如功能丧失突变可能引发免疫缺陷,而过度表达可能与自身免疫疾病(如类风湿关节炎、多发性硬化症)或移植排斥反应相关。在肿瘤微环境中,CD80表达下调可能帮助肿瘤逃避免疫监视。基因家族共性上,B7家族成员均通过受体配对(如CD28/CTLA-4、PD-1/PD-L1等)双向调节免疫反应,兼具激活和抑制功能。过表达CD80可能增强抗肿瘤免疫但也可能引发自身免疫损伤;而低表达会削弱免疫应答,增加感染或肿瘤风险。治疗上,靶向CD80/CTLA-4的抗体(如伊匹木单抗)已用于癌症免疫治疗,通过阻断抑制信号恢复T细胞活性。
The protein encoded by this gene is a membrane receptor that is activated by the binding of CD28 or CTLA-4. The activated protein induces T-cell proliferation and cytokine production. This protein can act as a receptor for adenovirus subgroup B and may play a role in lupus neuropathy. [provided by RefSeq, Aug 2011]
由该基因编码的蛋白质是由结合CD28或CTLA-4的活化的膜受体。活化的蛋白诱导T细胞增殖和细胞因子产生。这种蛋白质可以充当腺病毒亚组B中的受体和可能在狼疮神经病的作用。 [由RefSeq的,2011年8月提供]
CD80基因(以及对应的蛋白质)的细胞分布位置:
CD80基因的本体(GO)信息:
名称 |
---|
4514 Cell adhesion molecules (CAMs) [PATH:hsa04514] |
4620 Toll-like receptor signaling pathway [PATH:hsa04620] |
4672 Intestinal immune network for IgA production [PATH:hsa04672] |
5322 Systemic lupus erythematosus [PATH:hsa05322] |
5323 Rheumatoid arthritis [PATH:hsa05323] |
5320 Autoimmune thyroid disease [PATH:hsa05320] |
5330 Allograft rejection [PATH:hsa05330] |
5332 Graft-versus-host disease [PATH:hsa05332] |
5416 Viral myocarditis [PATH:hsa05416] |
4940 Type I diabetes mellitus [PATH:hsa04940] |
名称 |
---|
Adaptive Immune System |
CD28 co-stimulation |
CD28 dependent PI3K/Akt signaling |
CD28 dependent Vav1 pathway |
Constitutive Signaling by Aberrant PI3K in Cancer |
Costimulation by the CD28 family |
CTLA4 inhibitory signaling |
DAP12 interactions |
DAP12 signaling |
Disease |
Diseases of signal transduction |
Downstream signal transduction |
Downstream signaling events of B Cell Receptor (BCR) |
Downstream signaling of activated FGFR1 |
Downstream signaling of activated FGFR2 |
Downstream signaling of activated FGFR3 |
Downstream signaling of activated FGFR4 |
Fc epsilon receptor (FCERI) signaling |
GAB1 signalosome |
Immune System |
Innate Immune System |
NGF signalling via TRKA from the plasma membrane |
PI-3K cascade:FGFR1 |
PI-3K cascade:FGFR2 |
PI-3K cascade:FGFR3 |
PI-3K cascade:FGFR4 |
PI3K events in ERBB2 signaling |
PI3K events in ERBB4 signaling |
PI3K/AKT activation |
PI3K/AKT Signaling in Cancer |
PIP3 activates AKT signaling |
Role of LAT2/NTAL/LAB on calcium mobilization |
Signal Transduction |
Signaling by EGFR |
Signaling by ERBB2 |
Signaling by ERBB4 |
Signaling by FGFR |
Signaling by FGFR1 |
Signaling by FGFR2 |
Signaling by FGFR3 |
Signaling by FGFR4 |
Signaling by PDGF |
Signaling by SCF-KIT |
Signaling by the B Cell Receptor (BCR) |
Signalling by NGF |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Celiac Disease | 0.125005506 | 3 | 2 | BeFree_CTD_human_GAD |
Lupus Erythematosus, Systemic | 0.123995683 | 7 | 1 | BeFree_GAD_GWASCAT |
IGA Glomerulonephritis | 0.122995792 | 2 | 0 | BeFree_CTD_human_LHGDN |
Biliary cirrhosis | 0.12 | 1 | 0 | CTD_human |
Vitiligo | 0.12 | 1 | 0 | CTD_human |
Glioma | 0.080814326 | 4 | 0 | BeFree_RGD |
Experimental Autoimmune Encephalomyelitis | 0.080271442 | 2 | 0 | BeFree_RGD |
Periodontal Diseases | 0.080271442 | 2 | 0 | BeFree_RGD |
Renal Insufficiency | 0.08 | 0 | 0 | RGD |
Adult T-Cell Lymphoma/Leukemia | 0.08 | 1 | 0 | RGD |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。